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Mesenchymal stem cells (MSC) are considered promising tool in regenerative medi-
cine applications. Even if they are already applied clinically, their extended characteri-
zation is being increasingly viewed as a needed feature, in order to avoid contrasting 
results when translating “in vitro” experiments to “in vivo” approaches. We recently 
demonstrated in human MSC isolated from the umbilical cord matrix (HEMSC) the ex-
pression of novel markers indicative of their stemness, as well as differentiative and 
immune properties [1].
HEMSC were cultured and subject to multiple molecular and morphological analy-
ses to determine the expression of markers of interest.
Undifferentiated HEMSC expressed immunoregulatory molecules, both surface an-
tigens and secreted cytokines. In addition to the differential expression of B7 co-stimula-
tors (CD80+/CD86-), HEMSC expressed pregnancy-specific immunomodulatory mol-
ecules, together with non-classical type Ib MHC antigens. In fact, besides HLA-A and 
HLA-G, HEMSC expressed both HLA-E and HLA-F, two tolerance-promoting HLAs, 
involved in attenuating NK- and T-cytotoxic responses. In the continued characteriza-
tion of these cells, we assessed the expression of endoderm-related molecules, sugges-
tive of their possible transdifferentiation towards hepatocytes. In addition to HNF4α 
and endoderm-related GATA factors (GATA-4,-5,-6), undifferentiated cells expressed 
also albumin, cytokeratins 18 and 19, and further hepatocyte-enriched transcription fac-
tors (as HNF1α, and HNF1β), thus suggesting the possibility to be successfully differen-
tiated towards hepatocytes [2].
The immunological and differentiative properties of human extraembryonic MSC 
are under intense investigation. Our data suggest that HEMSC bear new markers and 
have a hypoimmunogenic phenotype which can be a favoring factor to ensure the en-
graftment of “in vivo” transplanted cells.
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